Pathological complete response to neoadjuvant ceritinib of a crizotinib‐resistant, stage IIIB non‐small cell lung cancer with ALK rearrangement: A case report

The treatment of stage IIIB non‐small cell lung cancer (NSCLC) is complicated, the best strategy is chosen individually and surgery is usually not recommended. A 50‐year‐old female was diagnosed with locally advanced lung adenocarcinoma (stage IIIB, T2bN3M0). Fluorescence in situ hybridization (FISH...

Descripción completa

Detalles Bibliográficos
Autores principales: Bing, Zhongxing, Jia, Ziqi, Wang, Yadong, Xue, Jianchao, Cao, Lei, Cao, Zhili, Liu, Peng, Li, Ji, Liang, Naixin, Li, Shanqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2021
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8287007/
https://www.ncbi.nlm.nih.gov/pubmed/34105864
http://dx.doi.org/10.1111/1759-7714.14045

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8287007/
https://www.ncbi.nlm.nih.gov/pubmed/34105864
http://dx.doi.org/10.1111/1759-7714.14045

Ejemplares similares